Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Is inappropriate left ventricular mass related to neurohormonal factors and/or arterial changes in hypertension? a LIFE substudy

Journal of Human Hypertension volume 18, pages 437–443 (2004)Cite this article

Abstract

We investigated whether inappropriately high left ventricular (LV) mass, defined as observed LV mass exceeding the level of individual LV mass predicted from gender, height, and stroke work, may be associated with an imbalance between growth-promoting and growth-inhibitory factors and/or structural vascular changes. In 53 patients with hypertension and electrocardiographic LV hypertrophy, 24-h ambulatory blood pressure (BP); echocardiographic LV mass, stroke volume and stroke work; minimal forearm vascular resistance (MFVR); and intima–media cross-sectional area in common carotid arteries (IMA) were evaluated after 2 weeks of placebo treatment. Serum insulin, plasma epinephrine, norepinephrine, endothelin, angiotensin II, aldosterone, and brain natriuretic peptide (BNP) were also measured. High observed LV mass was related to high IMA (r=0.46, P<0.001), MFVR (in men: r=0.36, P<0.05), 24-h ambulatory systolic BP (r=0.30, P=0.06), and lower plasma angiotensin II (r=−0.33, P<0.05), but not to other circulating growth factors. Stroke work was similarly related to IMA (r=0.42, P<0.01), MFVR (in men: r=0.41, P<0.05), and plasma angiotensin II (r=−0.32, P<0.05). Inappropriate LV mass, identified by the ratio between observed LV mass and the value predicted for gender, height, and stroke work, was not significantly related to any of the arterial or neurohormonal variables. In this small series of older hypertensive patients, inappropriate LV mass was not significantly related to arterial changes or to measured circulating growth factors, although weak relations cannot be excluded. Alternatively, inappropriately high LV mass might be related to unmeasured factors such as local myocardial alterations in growth factors and/or genetic predisposition to develop excessive LV hypertrophy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. de Simone G et al. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 1998; 31: 1077–1082.

    Article  CAS  PubMed  Google Scholar 

  2. Celentano A et al. Inappropriate left ventricular mass in normotensive and hypertensive patients. Am J Cardiol 2001; 87: 361–363.

    Article  CAS  PubMed  Google Scholar 

  3. Olsen MH et al. Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. Am Heart J 2002; 144: 530–537.

    Article  PubMed  Google Scholar 

  4. Inoue M et al. Impaired expression of brain natriuretic peptide gene in diabetic rats with myocardial infarction. Exp Clin Endocrinol Diabetes 1998; 106: 484–488.

    Article  CAS  PubMed  Google Scholar 

  5. Chen HH, Burnett JC . Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep 2000; 2: 198–205.

    Article  CAS  PubMed  Google Scholar 

  6. Ikeda M et al. Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997; 17: 731–736.

    Article  CAS  PubMed  Google Scholar 

  7. Yasumoto K et al. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension. Am J Hypertens 1999; 12: 921–924.

    Article  CAS  PubMed  Google Scholar 

  8. Olsen MH et al. Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia. J Hypertens 2000; 18: 75–81.

    Article  CAS  PubMed  Google Scholar 

  9. Dahlof B et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension 1998; 32: 989–997.

    Article  CAS  PubMed  Google Scholar 

  10. Devereux RB et al. Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. Circulation 1997; 96: 1416–1423.

    Article  CAS  PubMed  Google Scholar 

  11. Schiller NB et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358–367.

    Article  CAS  PubMed  Google Scholar 

  12. Palmieri V et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol 1999; 34: 1625–1632.

    Article  CAS  PubMed  Google Scholar 

  13. Howard G et al. Carotid artery intimal–medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993; 24: 1297–1304.

    Article  CAS  PubMed  Google Scholar 

  14. Roman MJ et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909–1918.

    Article  CAS  PubMed  Google Scholar 

  15. Folkow B . Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347–504.

    Article  CAS  PubMed  Google Scholar 

  16. Utriainen T, Malmstrom R, Makimattila S, Yki-Jarvinen H . Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia 1995; 38: 555–564.

    Article  CAS  PubMed  Google Scholar 

  17. Mulvany MJ, Halpern W . Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19–26.

    Article  CAS  PubMed  Google Scholar 

  18. Imai Y et al. The accuracy and performance of the A&D TM 2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens 1992; 5: 719–726.

    Article  CAS  PubMed  Google Scholar 

  19. Conway J, Coats A . Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens Suppl 1989; 7: S29–S32.

    Article  CAS  PubMed  Google Scholar 

  20. Andersen L et al. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993; 39: 578–582.

    CAS  PubMed  Google Scholar 

  21. Appel E et al. Determination of plasma catecholamines by means of radioenzymatic labelling and high pressure liquid chromatographic separation. Naunyn Schmiedebergs Arch Pharmacol 1981; 315: 233–239.

    Article  CAS  PubMed  Google Scholar 

  22. Poulsen K, Jorgensen J . An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrinol Metab 1974; 39: 816–825.

    Article  CAS  PubMed  Google Scholar 

  23. Millar JA et al. A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chim Acta 1980; 101: 5–15.

    Article  CAS  PubMed  Google Scholar 

  24. Kappelgaard AM, Nielsen MD, Giese J . Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chim Acta 1976; 67: 299–306.

    Article  CAS  PubMed  Google Scholar 

  25. Shimizu H et al. Stability of brain natriuretic peptide (BNP) in human blood samples. Clin Chim Acta 1999; 285: 169–172.

    Article  CAS  PubMed  Google Scholar 

  26. de Simone G et al. Relation of hemodynamics and risk factors to ventricular–vascular interactions in the elderly: the Cardiovascular Health Study. J Hypertens 2001; 19: 1893–1903.

    Article  CAS  PubMed  Google Scholar 

  27. Brilla CG . The cardiac structure–function relationship and the renin–angiotensin–aldosterone system in hypertension and heart failure. Curr Opin Cardiol 1994; 9 (Suppl 1): S2–S10.

    Article  PubMed  Google Scholar 

  28. de Simone G, Pasanisi F, Contaldo F . Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension 2001; 38: 13–18.

    Article  CAS  PubMed  Google Scholar 

  29. de Simone G et al. In vivo left ventricular anatomy in rats with two-kidney, one clip and one-kidney, one clip renovascular hypertension. J Hypertens 1992; 10: 725–732.

    Article  CAS  PubMed  Google Scholar 

  30. de Simone G et al. Influence of sodium intake on in vivo left ventricular anatomy in experimental renovascular hypertension. Am J Physiol. 1993; 264: H2103–H2110.

    CAS  PubMed  Google Scholar 

  31. Ganau A et al. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 1990; 81: 25–36.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge technical assistance by Lisa Krause in Ann Arbor, Michigan, USA, in measuring IMT, and Paulette A Lyle for assistance in preparation of the manuscript. This work was supported in part by the Grants from The Danish Medical Association Research Fund, Copenhagen, Denmark; The Becket-Foundation, Copenhagen, Denmark; Editor and Mrs. Anders Christian Kaarsens Foundation, Copenhagen, Denmark; and Merck & Co, Inc, West Point, PA, USA as part of the LIFE ICARUS substudy.

Author information

Authors and Affiliations

  1. Department of Clinical Physiology and Nuclear Medicine, Glostrup Hospital, University of Copenhagen, Glostrup, Denmark

    M H Olsen & H Dige-Petersen

  2. Department of Internal Medicine, Glostrup Hospital, University of Copenhagen, Glostrup, Denmark

    M H Olsen, K Wachtell, H Ibsen & J Rokkedal

  3. Department of Medicine, Weill Medical College of Cornell University, New York, USA

    K Wachtell, G de Simone, V Palmieri & R B Devereux

  4. Department of Clinical and Experimental Medicine, Federico II University Hospital, Naples, Italy

    G de Simone & V Palmieri

Authors
  1. M H Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Wachtell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G de Simone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V Palmieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Dige-Petersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R B Devereux
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H Ibsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J Rokkedal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M H Olsen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olsen, M., Wachtell, K., de Simone, G. et al. Is inappropriate left ventricular mass related to neurohormonal factors and/or arterial changes in hypertension? a LIFE substudy. J Hum Hypertens 18, 437–443 (2004). https://doi.org/10.1038/sj.jhh.1001720

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001720

Keywords

This article is cited by

Search

Advanced search

Quick links